Hatem M. Elghezal - Genetic Mutations

Author Information

Hatem M. Elghezal is an accomplished researcher affiliated with the Cytogenetics and Molecular Genetics Division at Prince Sultan Military Medical City in Riyadh, Saudi Arabia. His research primarily focuses on cytogenetics and molecular genetics, contributing significantly to the understanding of various genetic syndromes and chromosomal abnormalities.

Research Contributions

Hatem M. Elghezal has made substantial contributions to the field of genetics through his extensive research on chromosomal abnormalities, genetic syndromes, and their clinical implications. Notable among his works are studies on X-linked ichthyosis, mantle cell lymphoma, and 22q11.2 deletion syndrome. His research spans various genetic disorders, including acute lymphoblastic leukemia and congenital malformations, providing valuable insights into molecular cytogenetic characterization and genotype-phenotype correlations.

Aliases

H. Elghezal, H Elghèzal, H Elghezal, Hatem M. Elghezal, Hatem Elghezal

Publication and Citation Metrics

Metric	Value
Total Citation Count	1171
h-index	22
Total Number of Papers	69

Publications:

Hypospadias in ring X syndrome.

DOI: 10.1016/j.ejmg.2021.104225

Year: 2021

Epilepsy, neuropsychiatric phenotypes, neuroimaging findings, and genotype-neurophenotype correlation in 22q11.2 deletion syndrome

DOI: 10.17712/nsj.2020.4.20200045

Year: 2020

De Novo Ring Chromosome 15: Molecular Cytogenetic and Clinical Characterization of First Case from Saudi Arabia

DOI: 10.1055/s-0040-1721135

Year: 2020

Rare cytogenetic abnormalities and their clinical relevance in pediatric acute leukemia of Saudi Arabian population

DOI: 10.1186/s13039-019-0454-0

Year: 2019

Cytogenetic Profile and FLT3 Gene Mutations of Childhood Acute Lymphoblastic Leukemia

DOI: 10.1177/1179554917721710

Year: 2017

Severe Expressive-Language Delay and Congenital Malformations in a Boy with Microduplication 7q11.23 Diagnosed by Molecular Cytogenetic Analysis

DOI: 10.4172/2327-5790.1000127

Year: 2016

Microarray Analysis of 8p23.1 Deletion in New Patients with Atypical Phenotypical Traits.

DOI: 10.1055/s-0035-1565269

Year: 2015

De Novo CD5 Negative Blastic Mantle Cell Lymphoma Presented with Massive Bone Marrow Necrosis without Adenopathy or Organomegaly

DOI: 10.1155/2015/146598

Year: 2015

Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality

DOI: 10.4137/CPath.S17818

Year: 2014

Xp22.3 interstitial deletion: a recognizable chromosomal abnormality encompassing VCX3A and STS genes in a patient with X-linked ichthyosis and mental retardation.

DOI: 10.1016/j.gene.2013.06.018

Year: 2013

How is the Delta F508 Mutation Inherited?

What Causes Sickle Cell Anemia?

Who Should Consider PARP Inhibitors?

How does Research Advance Treatment?

How is Data Collected in Populace Genomics?

What is CRISPR Technology?

What Are the Advantages of Using CGH?

What Types of Cancers Are Linked to Asbestos Exposure?

Why Study Genetic Mutations?

How does BLAST work?

Partnered Content Networks

Relevant Topics